Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Cagrilintide/semaglutide

A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet

Novo Nordisk · Phase 1 · Active, not recruiting · Enrollment 80

NCT07184086

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
CagriSema (Cagrilintide + Semaglutide) / CagriSeman/rn/rn/rn/r
Low Energy Diet (LED) / CagriSeman/rn/rn/rn/r

Not shown

  • CagriSema (Cagrilintide + Semaglutide) / CagriSema: endpoint not reported
  • Low Energy Diet (LED) / CagriSema: endpoint not reported